Basis for the Management of Drug-Resistant Helicobacter pylori Infection

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.17, 2004-01, pp. : 1893-1904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clarithromycin for Helicobacter pylori infection

By Leung W.K. Graham D.Y.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 507-514

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori infection in children: management and pharmacotherapy

By Sabbi Tamara De Angelis Paola Dall'Oglio Luigi

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 577-585

Informa Healthcare

Access to resources Recommend Favorite

NSAID-Induced Peptic Ulcers and Helicobacter pylori Infection: Implications for Patient Management

By Chan Francis K.L.

Drug Safety, Vol. 28, Iss. 4, 2005-01 ,pp. : 287-300

Adis International

Access to resources Recommend Favorite

Strategy for the Treatment of Helicobacter pylori Infection

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4489-4500

Bentham Science Publishers

Access to resources Recommend Favorite

Updated guidelines for Helicobacter pylori infection

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite